We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Its strategic focus encompasses diverse therapeutic areas, such as oncology and cardiovascular disease ... for the quarter (up 3%). These products underscore Amgen's capacity to seize growth ...
With a market cap of $142 billion, Amgen has been a pioneer in the biotechnology industry for over 40 years. Its portfolio includes treatments for cancer, heart disease, osteoporosis, inflammatory ...
Founded in 1980 to pioneer genetic engineering techniques, Amgen (NASDAQ:AMGN) is a biotechnology company that develops medicines, focusing on treatments in oncology (cancers), cardiology (heart ...
Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Management anticipates continued growth in key products like Repatha ... pressures in obesity and cardiovascular markets, emphasizing the need for differentiation. Amgen delivered strong financial ...